Biotechnology What’s Going On With Candel Therapeutics Stock On Friday? – Candel Therapeutics (NASDAQ:CADL) Read more
Biotechnology After Brain Cancer Data, Candel Therapeutics’ Shares Good News From Pancreatic Cancer Study Why Candel Therapeutics Stock Is Soaring On Thursday – Candel Therapeutics (NASDAQ:CADL) Read more
Biotechnology Chief Science Officer Talks Innovation In Cancer Research – Candel Therapeutics (NASDAQ:CADL) Read more
Eurozone Nasdaq Surges 1%; ConAgra Brands Posts Upbeat Earnings – Allurion Technologies (NYSE:ALUR), Achilles Therapeutics (NASDAQ:ACHL) Read more
Eurozone Dow Dips Over 200 Points; RPM International Shares Fall After Q3 Results – Allurion Technologies (NYSE:ALUR), Achilles Therapeutics (NASDAQ:ACHL) Read more
Biotechnology The CEO Of This Innovative BioPharma Is Bringing Light To Cancer Research – Candel Therapeutics (NASDAQ:CADL) Read more
Biotechnology Candel Therapeutics (NASDAQ: CADL) Lead Product Candidate CAN-3110 Demonstrates Promise To Treat Deadly Brain Tumors – Candel Therapeutics (NASDAQ:CADL) Read more
Biotechnology Could This Common Virus Unlock New Cancer Treatments? Theriva Biologics Believes That Adenoviruses Could Be Instrumental In The Next Evolution Of Oncology – Candel Therapeutics (NASDAQ:CADL), CG Oncology (NASDAQ:CGON) Read more
Biotechnology Moving Fast: Candel’s (NASDAQ: CADL) CAN-3110 Granted FDA Fast Track Designation For Recurrent High-Grade Glioma Following Fast Track Designation For CAN-2409 In Pancreatic Cancer – Candel Therapeutics (NASDAQ:CADL) Read more
